.
MergerLinks Header Logo

Announced

Completed

RefleXion Medical raised $100m in a PSP Investments-led Series D funding round.

Financials

Edit Data
Transaction Value£79m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Minority

Health Care Services

Friendly

Medical Equipment

Acquisition

Private Equity

radiotherapy

Venture Capital

Completed

United States

Private

Single Bidder

Synopsis

Edit

RefleXion Medical, a therapeutic oncology company, raised $100m in a PSP Investments-led Series D funding round. RefleXion's existing investors, TPG's The Rise Fund, KCK Group, Sofinnova Partners, Venrock, T. Rowe Price, Pfizer Ventures and Johnson & Johnson Innovation all participated in the round. "This new influx of capital continues our momentum initiated first by FDA clearance of the RefleXion™ X1 platform last month, then quickly followed by the close of our first system order at one of the world's leading cancer centers. The support of this top-tier investment syndicate enables us to further scale operations around commercializing the X1 platform," Todd Powell, RefleXion President and CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US